BCLSI
SYRS
Bain Capital Life Sciences Investors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,750,151
| Closed | -$632K | – | 25 |
|
|
2024
Q4 | $632K | Hold |
2,750,151
| – | – | 0.07% | 26 |
|
|
2024
Q3 | $5.91M | Buy |
2,750,151
+343
| +0% | +$737 | 0.62% | 19 |
|
|
2024
Q2 | $14.2M | Hold |
2,749,808
| – | – | 1.56% | 12 |
|
|
2024
Q1 | $14.7M | Hold |
2,749,808
| – | – | 1.18% | 17 |
|
|
2023
Q4 | $21.4M | Buy |
2,749,808
+625,114
| +29% | +$4.87M | 2.05% | 12 |
|
|
2023
Q3 | $8.39M | Hold |
2,124,694
| – | – | 0.94% | 22 |
|
|
2023
Q2 | $6.69M | Hold |
2,124,694
| – | – | 0.69% | 26 |
|
|
2023
Q1 | $5.67M | Hold |
2,124,694
| – | – | 0.71% | 27 |
|
|
2022
Q4 | $7.63M | Buy |
2,124,694
+1,042,290
| +96% | +$3.74M | 0.85% | 25 |
|
|
2022
Q3 | $6.97M | Sell |
1,082,404
-5,182,016
| -83% | -$33.4M | 0.83% | 24 |
|
|
2022
Q2 | $6.03M | Hold |
6,264,420
| – | – | 0.71% | 26 |
|
|
2022
Q1 | $7.46M | Hold |
6,264,420
| – | – | 0.72% | 25 |
|
|
2021
Q4 | $20.4M | Buy |
6,264,420
+479,384
| +8% | +$1.56M | 1.62% | 17 |
|
|
2021
Q3 | $25.9M | Hold |
5,785,036
| – | – | 1.6% | 15 |
|
|
2021
Q2 | $31.5M | Hold |
5,785,036
| – | – | 2.07% | 12 |
|
|
2021
Q1 | $43.3M | Hold |
5,785,036
| – | – | 2.45% | 11 |
|
|
2020
Q4 | $62.8M | Buy |
+5,785,036
| New | +$62.8M | 3.94% | 7 |
|